Research and Markets (http://www.researchandmarkets.com/research/e45ece/ribonucleic_acid)
has announced the addition of the "Ribonucleic
Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in
Pharma" report to their offering.
“Ribonucleic
Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in
Pharma”
Ribonucleic
Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in
Pharma provides insights into the unmet needs in the pharmaceutical
and healthcare market and potential segments where RNA therapies can
prove to be useful. This pharma report also delves deep into the market
potential that RNA therapies hold in the future. Further, it provides
insights into the R&D pipeline and the promising drugs. The study
elucidates the current competitive landscape of the RNA therapeutics
market. Finally, the report deals with key trend analysis on mergers and
acquisitions, and licensing agreements involving RNA therapies.
This report is built using data and information sourced from proprietary
databases, primary and secondary research and in-house analysis by a
team of industry experts.
Scope
The scope of this report includes:
-
Detailed market characterization including evaluation of market
potential, annual cost of therapy and treatment usage patterns
-
Key technologies that have created significant impact on research and
development of RNA therapeutics
-
Key factors that can drive the RNA therapeutics market potential
-
Key risks and issues associated with various RNA therapies
-
Competitive landscape of RNA therapeutics market. The key companies
studied in this report are Antisense Pharma GmbH, Lorus Therapeutics,
Isis Pharmaceuticals, Alfacell Corporation, Genta Incorporated,
Atlantic Healthcare, Alnylam, OPKO, Oxford BioMedica, Dicerna
Pharmaceuticals, Silence Therapeutics plc, Cequent Pharmaceuticals,
Inc and Santaris Pharma.
-
Key M&A activities and licensing agreements that have taken place
between 2008 and 2009 in the RNA therapeutics market.
Reasons to buy
The report will aid business development and marketing executives in
strategizing their product launches and help venture capitalists to
identify promising small and medium sized enterprises. It will allow you
to